Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

Fresenius Kabi to buy Merck KGaA biosimilar candidates

Fresenius Kabi has announced plans to purchase Merck KGaA’s biosimilars business. 


Getting a feel for biomanufacturing at the Biotech Training Facility

Hands-on teaching offers drugmakers, vendors and regulators a better understanding of bioprocessing, according to the managing director of a training facility in Leiden, The Netherlands.

Samsung Bioepis to take on J&J with FDA approved Remicade biosimilar

Samsung Bioepis’ Renflexis has become the second biosimilar of rheumatoid arthritis biologic Remicade (infliximab) to be recommended for approval in the US.

Filtration is a ‘high value process at a marginal cost,’ says Danaher

Danaher reported mid-single-digit growth from its bioprocessing subsidiary Pall Life Science and expects a continued trajectory to support Biopharma’s filtration needs.

BPI Europe 2017: Biomanufacturing industry goes Dutch

The bioprocessing industry has donned its clogs and made its way to Amsterdam. And Biopharma-Reporter is here too, bringing you the best of BPI Europe 2017.


US FDA warns Lonza about Walkersville site

The US FDA has warned Lonza about operations at its facility in Walkersville, Maryland, raising concerns about validation and aseptic process simulations.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...